Thrombin alfa
Key facts
Active substance |
thrombin alfa
|
Therapeutic area |
Haematology-Hemostaseology
|
Decision number |
P/62/2008
|
PIP number |
Thrombin alfa
|
Pharmaceutical form(s) |
Powder and solvent for reconstitution
|
Condition(s) / indication(s) |
Haemorrhage complicating a surgical procedure
|
Route(s) of administration |
Epilesional use
|
Contact for public enquiries |
Bayer HealthCare AG
|
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|